Episode

Author Interview: Professor Filip Rob, 2025

Podcast
The IMID Forum
Published
Nov 20, 2025
Duration seconds
1507
Processing state
not_requested
Canonical source
https://soundcloud.com/imidforum/author-interview-professor-filip-rob-2025
Audio
https://feeds.soundcloud.com/stream/2215233431-imidforum-author-interview-professor-filip-rob-2025.mp3
JSON
/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-filip-rob-2025
Markdown
/podcast/the-imid-forum-981476/author-interview-professor-filip-rob-2025.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-filip-rob-2025/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-filip-rob-2025.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Filip Rob, the Department of head of the Dermatovenereology at the Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic, as they discuss his recent paper ‘Efficacy, safety, and drug survival during the first year of biologic therapy for psoriasis in elderly versus younger patients’.